Narrow search
Showing 11 - 20 of 125
Cover Image
HEALTH - The Next Cancer Bestseller? Novartis has ambitious plans for its new kidney cancer drug.
Langreth, Robert - In: Forbes : business and finance (2009), pp. 58-59
Persistent link: https://www.econbiz.de/10008248894
Cover Image
Microsoft Versus GE: The Fight Over Your Medical Records - Digitizing medical data is easy. Using it to improve care will be hard.
Langreth, Robert - In: Forbes : business and finance (2009), pp. 40-43
Persistent link: https://www.econbiz.de/10008248902
Cover Image
Beaker Fuel - Designer biofuels looked great at $140 oil. How about at $65?
Langreth, Robert - In: Forbes : business and finance (2008), pp. 58-63
Persistent link: https://www.econbiz.de/10008151829
Cover Image
HEALTH - Biotech Blues - The downturn is getting ugly for young biotech companies. Will a generation of innovators be put on ice?
Langreth, Robert - In: Forbes : business and finance (2009), pp. 90-91
Persistent link: https://www.econbiz.de/10008162000
Cover Image
Nassim Taleb: How to Survive Market Chaos - How is Wall Street like the Titanic? The author of The Black Swan has a theory.
Langreth, Robert - In: Forbes : business and finance (2009), pp. 20-21
Persistent link: https://www.econbiz.de/10008169653
Cover Image
Good Medicine: When to Say No to Your Doctor - How much of the $2.5 trillion we spend on health care goes down the drain for tests and treatments that don't help, run up the bill a...
Langreth, Robert - In: Forbes : business and finance (2009), pp. 64-73
Persistent link: https://www.econbiz.de/10008334075
Cover Image
CAREERS - First Down and 60 - Being chief executive of TD Ameritrade wasn't enough; Joe Moglia tries college football.
Langreth, Robert; Herper, Matthew - In: Forbes : business and finance (2010), pp. 48-51
Persistent link: https://www.econbiz.de/10008351540
Cover Image
Medical Technology - Stem Cells Get Real - Stem cells are the fountain of youth -- Or the tools of Satan. It depends on whom you ask. Somewhere in between are pioneering companies...
Langreth, Robert; Herper, Matthew - In: Forbes : business and finance (2008), pp. 86-99
Persistent link: https://www.econbiz.de/10008064427
Cover Image
The Accidental Manager - Carl Icahn seems serious: He is interested in the long-term prosperity of biotech ImClone.
Langreth, Robert - In: Forbes : business and finance (2008), pp. 42-45
Persistent link: https://www.econbiz.de/10008069185
Cover Image
EXECUTIVE HEALTH - Taking Aim at Brain Cancer - Smarter matching of drugs to patients is likely to improve on the lukewarm results seen so far with targeted cancer therapies.
Langreth, Robert - In: Forbes : business and finance (2008), pp. 66-69
Persistent link: https://www.econbiz.de/10008097686